Skip to main content
OpenTrials
Completed

NCT Number: NCT01134159

Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

Multicenter, retrospective registry to collect 9-12 month follow-up data to evaluate major adverse cardiac events in patients whom have undergone percutaneous coronary intervention and received either Taxus Liberte or Xience V.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronary Artery Disease Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Washington Hospital Center, Washington D.C., District of Columbia, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients 18 years of age or older, both genders
  • Underwent PCI with Taxus Liberte (alone) or Xience (alone)

Exclusion criteria

  • Underwent PCI with a non-Taxus Liberte or Xience V DES during the same procedure
  • Received both Taxus-Liberte and Xience-V during the same index procedure
  • Patients not taking, or unable to take, dual antiplatelet therapy (aspirin plus clopidogrel or prasugrel).

Treatment and study plan

Primary outcomes

  1. Major adverse cardiac events,

    Time frame: 1 year

    A composite of all-cause death, Q-wave myocardial infarction, and target vessel revascularization

Secondary outcomes

  1. Stent thrombosis

    Time frame: 1 year

  2. Target vessel revascularization

    Time frame: 1 year

  3. Cardiac death

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Medstar Health Research Institute

Other

Collaborators

  • Boston Scientific Corporation

Registry information

Official study title

Registry Experience at the WAshington Hospital CenteR, DeS - Taxus Liberte vs Xience V

Acronym: REWARDS TLX

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
May 31, 2010
Registry last updated
Jun 2, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.